Effects of psychotomimetic and antipsychotic agents on neocortical and striatal concentrations of various amino acids in the rat

Journal of Neurochemistry

Volumn 90, Issue 6, 2004, Pages 1378-1388

  Sakurai, Shin Ichiro ^a   Ishii, Sumikazu ^a   Umino, Asami ^a   Shimazu, Dai ^a   Yamamoto, Naoki ^a   Nishikawa, Toru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antipsychotics; L arginine; L asparagine; Metamphetamine; Neocortex; Striatum

Indexed keywords

ALANINE; AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; CLOZAPINE; DOPAMINE; GLUTAMIC ACID; GLYCINE; HALOPERIDOL; METHAMPHETAMINE; NEUROLEPTIC AGENT; PHENCYCLIDINE; PSYCHEDELIC AGENT; SERINE; THREONINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; STRIATE CORTEX;

AMINO ACIDS; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOZAPINE; CORPUS STRIATUM; DRUG INTERACTIONS; HALOPERIDOL; MALE; METHAMPHETAMINE; MIXED FUNCTION OXYGENASES; NEOCORTEX; RATS; RATS, WISTAR; TIME FACTORS;

ANIMALIA;

EID: 4544287024     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02592.x     Document Type: Article

References (52)

1. A Receptors and Anxiety. Raven Press, New York.
2. Bonetti E. P., Burkard W. P., Gabl M., Hunkeler W., Lorez H. P., Martin J. R., Moehler H., Osterrieder W., Pieri L. and Polc P. (1988) Ro 15-4513: partial inverse agonism at the BZR and interaction with ethanol. Pharmacol. Biochem. Behav. 31, 733-749.
3. Braestrap C., Schmiechen R., Neef G., Nielsen M. and Petersen E. N. (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216, 1241-1243.
4. Bustamante D., You Z. B., Castel M. N., Johansson S., Goiny M., Terenius L., Hokfelt T. and Herrera-Marschitz M. (2002) Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J. Neurochem. 83, 645-654.
5. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M. and Carlsson M. L. (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41, 237-260.
6. Contreras P. C. (1990) D-Serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology 29, 291-293.
7. Danysz W. and Parsons A. C. (1998) Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev. 50, 597-664.
8. Dieterich D. C., Landwehr M., Reissner C., Smalla K. H., Richter K., Wolf G., Bockers T. M., Gundelfinger E. D. and Kreutz M. R. (2003) Gliap - a novel untypical L-asparaginase localized to rat brain astrocytes. J. Neurochem. 85, 1117-1125.
9. Flaum M. and Schultz S. K. (1996) When does amphetamine-induced psychosis become schizophrenia? Am. J. Psychiatry 153, 812-815.
10. Hashimoto A., Nishikawa T., Oka T. and Takahashi K. (1991) D-Alanine inhibits methamphetamine-induced hyperactivity in rats. Eur. J. Pharmacol. 202, 105-107.
11. Hashimoto A., Nishikawa T., Hayashi T., Fujii N., Harada K., Oka T. and Takahashi K. (1992a) The presence of free D-serine in rat brain. FEBS Lett. 296, 33-36.
12. Hashimoto A., Nishikawa T., Oka T., Takahashi K. and Hayashi T. (1992b) Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde. J. Chromatogr. 582, 41-48.
13. Hashimoto T., Kajii Y and Nishikawa T. (1998) Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain. Eur. J. Neurosci. 10, 3387-3399.
14. Hollmann M. and Heinemann S. (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31-108.
15. Huxtable R. J. (1992) Physiological actions of taurine. Physiol. Rev. 72, 101-163.
16. G-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release. J. Pharmacol. Exp. Ther. 277, 1424-1430.
17. Javitt D. C. (2002) Glycine modulators in schizophrenia. Curr. Opin. Invest. Drugs 3, 1067-1072.
18. Kubota Y., Ito C., Sakurai E., Sakurai E., Watanabe T. and Ohtsu H. (2002) Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J. Neurochem. 83, 837-845.
19. Kuriyama K. and Ohkuma S. (1995) Role of nitric oxide in central synaptic transmission: effects on neurotransmitter release. Jpn J. Pharmacol. 69, 1-8.
20. 4 receptors in rat frontal cortex. J. Neural Transm. 101, 231-235.
21. Mikami T., Naruse N., Fukura Y., Ohkubo H., Ohkubo T., Matsuura M., Moriya H., Nishikawa T. and Kojima T. (2003) Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements. Psychiatry. Clin. Neurosci. 57, 433-440.
22. Miyamoto S., Duncan G. E., Goff D. C. and Lieberman J. A. (2002) Therapeutics of schizophrenia, in Neuropsychopharmacology; the Fifth Generation of Progress (Davis K. L., Charney D., Coyle J. T. and Nemeroff C., eds), pp. 775-807. Lippincott, Williams & Wilkins, Philadelphia.
23. Nishijima K., Kashiwa A. and Nishikawa T. (1994) Preferential stimulation of extracellular release of dopamine in rat frontal cortex and striatum as following competitive inhibition of the N-methyl-D-aspartate receptor. J. Neurochem. 63, 375-378.
24. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A. and Nishikawa T. (1996) Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat medial frontal cortex and striatum as revealed by in vivo dialysis. Synapse 22, 304-312.
25. Nishikawa T., Malaga N., Takashima M. and Toru M. (1983) Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur. J. Pharmacol. 88, 195-203.
26. Ogawa M., Shigeto H., Yamamoto T., Oya Y., Wada K., Nishikawa T. and Kawai M. (2003) D-cycloserine for the treatment of ataxia in spinocerebellar degeneration. J. Neurol. Sci. 210, 53-56.
27. Ohno M. and Watanabe S. (1995) Nitric oxide synthase inhibitors block behavioral sensitization to methamphetamine in mice. Eur. J. Pharmacol. 275, 39-44.
28. Olsen R. W. (2002) GABA. In: Neuropsychopharmacology; the Fifth Generation of Progress (Davis K. L., Charney D., Coyle J. T. and Nemeroff C., eds), pp. 159-168. Lippincott, Williams & Wilkins, Philadelphia.
29. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Cordinates (2nd edn). Academic Press, Sydney.
30. Qiao H., Noda Y., Kamei H., Nagai T., Furukawa H., Miura H., Kayukawa Y., Ohta T. and Nabeshima T. (2001) Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. Neuroreport 12, 11-15.
31. Ramirez de Guglielmone A. E. and Gomez C. J. (1966) Free amino acids in different areas of rat brain. Acta Physiol. Pharmacol. Latinoam. 16, 26-37.
32. Reubi J. C., Toggenburger G. and Cuenod M. (1980) Asparagine as precursor for transmitter aspartate in corticostriatal fibres. J. Neurochem. 35, 1015-1017.
33. Sams-Dodd F. (1996) Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav. Pharmacol. 7, 3-23.
34. Sato M. (1992) A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann. N. Y. Acad. Sci. 654, 160-170.
35. Seiden L. S., Sabol K. E. and Ricaurte G. A. (1993) Amphetamine: effects on catecholamine systems and behaviour. Annu. Rev. Pharmacol. Toxicol. 33, 639-677.
36. Sesack S. R., Carr D. B., Omelchenko N. and Pinto A. (2003) Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann. N. Y. Acad. Sci. 1003, 36-52.
37. Shirayama Y., Mitsushio H., Takahashi K. and Nishikawa T. (2000) Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions. Synapse 35, 292-299.
38. Shoblock J. R., Sullivan E. B., Maisonneuve I. M. and Click S. D. (2003) Neurochemical and behavioral differences between D-methamphetamine and D-amphetamine in rats. Psychopharmacology 165, 359-369.
39. Southam E., East S. J. and Garthwaite J. (1991) Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development. J. Neurochem. 56, 2072-2081.
40. Strasser A., McCarron R. M., Ishii H., Stanimirovic D. and Spatz M. (1994) L-arginine induces dopamine release from the striatum in vivo. Neuroreport 5, 2298-2300.
41. Takahashi K., Hayashi F. and Nishikawa T. (1997) In vivo evidence for the link between L- and D-serine metabolism in rat cerebral cortex. J. Neurochem. 69, 1286-1290.
42. Tanii Y., Nishikawa T., Hashimoto A. and Takahashi K. (1991) Stereo-selective inhibition by D- and L-alanine of phencyclidine-induced locomotor stimulation in the rat. Brain Res. 563, 281-284.
43. Tanii Y., Nishikawa T., Hashimoto A. and Takahashi K. (1994) Stereo-selective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J. Pharmacol. Exp. Ther. 269, 1040-1048.
44. Tekin S. and Cummings J. L. (2002) Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J. Psychosom. Res. 53, 647-654.
45. Tomiyama G. (1990) Chronic schizophrenia-like states in methamphetamine psychosis. Jpn J. Psychiatry Neurol. 44, 531-539.
46. Tossman U., Jonsson G. and Ungerstedt U. (1986) Regional distribution and extracellular levels of amino acids in rat central nervous system. Acta Physiol. Scand. 127, 533-545.
47. Ujike H., Ogawa N. and Otsuki S. (1998) Effects of acute and long-term treatment with methamphetamine on substance P concentration and receptor numbers in the rat brain. Brain Res. 453, 136-142.
48. Umino A., Takahashi K. and Nishikawa T. (1998) Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat. Br. J. Pharmacol. 124, 377-385.
49. Vanderschuren L. J. and Kalivas P. W. (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151, 99-120.
50. Waagepetersen H. S., Sonnewald U. and Schousboe A. (2003) Compartmentation of glutamine, glutamate, and GABA metabolism in neurons and astrocytes: functional implications. Neuroscientist 9, 398-403.
51. Yonezawa Y., Matsumoto T., Tsutsumi T., Nakamura K., Hirano M., Hondoh H., Hashimoto K. and Uchimura H. (1992) Effects of phencyclidine on amino acids in discrete brain regions of rat. Neurochem. Res. 17, 652-653.
52. Zhang Y., Loonam T. M., Noailles P. A. and Angulo J. A. (2001) Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann. N. Y. Acad. Sci. 937, 93-120.